Pfizer Inc. (NYSE:PFE) Is Favoured by Institutional Owners Who Hold 68% of the Company

Yahoo Finance19:00

Si Usted Compró, Pagó O Proporcionó Un Reembolso Por Una Parte O La Totalidad Del Precio De Lipitor De Marca O Su Equivalente Genérico, Atorvastatina Cálcica, Usted Podría Obtener Dinero De Una Conciliación

TRENTON, N.J., 3 de julio de 2024 /PRNewswire-HISPANIC PR WIRE/ -- SUS DERECHOS LEGALES PUEDEN VERSE AFECTADOS Existe una conciliación propuesta en una demanda colectiva presentada contra Pfizer Inc

PR Newswire11:30

What the Options Market Tells Us About Pfizer

Financial giants have made a conspicuous bearish move on Pfizer. Our analysis of options history for Pfizer (NYSE:PFE) revealed 8 unusual trades.Delving into the details, we found 37% of traders were

Benzinga02:01

GSK Will Pay Up to $1.5 Billion for CureVac's MRNA Vaccines -- Barrons.com

By Josh Nathan-Kazis The drugmaker GSK plunged into the messenger RNA-based vaccine market Wednesday, announcing it will buy the rights to experimental influenza and Covid-19 mRNA vaccines from the b

Barron'sJul 3 22:18

Pfizer (PFE) Stock Falls in a Year: Time to Buy, Sell or Hold?

Zacks Jul 3 20:20

GSK Buys Full Rights To Investigational Covid-19 And Influenza Vaccines From CureVac For Around $1.5B

Wednesday, GSK plc (NYSE:GSK) and CureVac N.V. (NASDAQ:CVAC) announced they have restructured their existing collaboration into a new licensing agreement, allowing the companies to prioritize investme

BenzingaJul 3 20:01